Epic Health Revolution: Adam Mendelsohn's GLP-1 Breakthroughs and Transformative Obesity Solutions

Welcome to another episode of Boombostic Health in the Wild, recorded live from the JPMorgan Healthcare Conference 2025. Join us as we engage with Adam Mendelsohn, CEO of Vivani Medical, Inc., to explore pioneering advancements in healthcare and the future of obesity treatment.

In this episode, we cover:

• Adam's Journey into Healthcare: Discover how Adam's early exposure to medical device companies, influenced by his father, set the stage for his career in healthcare innovation. Learn about his experiences at MiniMed and how they shaped his entrepreneurial path.

• GLP-1 Medications: Understand the significance of GLP-1 medications in combating obesity and diabetes. We discuss their mechanism, benefits, and the challenges of medication adherence that Vivani aims to address.

• Vivani's Innovative Implant Technology: Dive into Vivani's groundbreaking implant technology designed to enhance medication adherence. Learn how this small implant offers a six-month treatment solution, potentially transforming patient care and health outcomes.

• The Obesity Epidemic: Engage in a thought-provoking discussion on the obesity crisis, the role of lifestyle changes versus medication, and the societal factors influencing health behaviors. Explore the potential of GLP-1 as a catalyst for sustainable lifestyle changes.

• Market Opportunities and Business Insights: Gain insights into the GLP-1 market, valued at $50-$60 billion annually, and the business potential of Vivani's innovations. Understand the regulatory pathways and the financial implications of bringing new healthcare solutions to market.

 

Tune in to discover how these innovations are shaping the future of healthcare, offering hope and solutions for obesity and diabetes management. Perfect for healthcare professionals, innovators, and anyone interested in the cutting-edge of health tech!